drugset / Trial / NCT06946914
Misoprostol Before Caesarean Section
RandomizedParallel-groupSingle-blindPrevention
Summary
The aim of our study is to evaluate the efficacy of Misoprostol before elective cesarean section in pregnant women with gestational age less than 38 weeks for preventing the occurrence of neonatal respiratory morbidity.
Timeline
- Start
- 2024-06-01
- Primary completion
- 2025-06-01
- Completion
- 2025-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Misoprostol | Other / unclassified | 100 ug | Oral |